Registry for the safe use of NeuroAiD in brain injury patients
NeuroAiD Safe Treatment Registry
This study is trying to see if NeuroAiD is safe and helpful for people with brain injuries by collecting information from doctors about their patients' experiences.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Sex | All |
| Sponsor | CHIMES Society Academic / other |
| Locations | 2 sites (Jakarta and 1 other locations) |
| Trial ID | NCT02536079 on ClinicalTrials.gov |
What this trial studies
The NeuroAiD Safe Treatment Registry is an observational registry aimed at assessing the real-world use and safety of NeuroAiD in patients with brain injuries. It involves an online system for easy data entry and retrieval of clinical information, including demographics, medical conditions, and neurological assessments. Physicians will prospectively enter data at baseline and during follow-up visits, with a target sample size of 2000 participants. The collected anonymized data will be analyzed to evaluate the treatment's effectiveness and safety.
Who should consider this trial
Good fit: Ideal candidates for this registry are individuals of any age who are currently taking or have been prescribed NeuroAiD.
Not a fit: Patients who are unwilling to participate or have contraindications to NeuroAiD may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could provide valuable insights into the safety and efficacy of NeuroAiD for patients with brain injuries.
How similar studies have performed: While this registry approach is not novel, it builds on existing frameworks for monitoring treatment safety and efficacy in clinical practice.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female * Any age * Taking, or has been prescribed NeuroAiD for any duration as judged by the physician and/or the participant * Agrees to be included in the registry and allows retrieval and analysis of data in accordance with local requirements Exclusion Criteria: * Unwillingness to participate * Contraindication to NeuroAiD
Where this trial is running
Jakarta and 1 other locations
- National Brain Center Hospital — Jakarta, Indonesia (Recruiting)
- University Kebangsaan Malaysia Medical Centre — Kuala Lumpur, Malaysia (Recruiting)
Study contacts
- Principal investigator: Ramesh Kumar, FRCS — Department of Neurosurgery, Faculty of Medicine, University Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia
- Study coordinator: Emily Lim
- Email: emily.lim@moleac.com
- Phone: +6562113710
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.